Cargando…

Trends and projections of ovarian cancer incidence in Hong Kong: A population‐based study

INTRODUCTION: This study analyzed the incidence of ovarian cancer in Hong Kong and its association with age, calendar period and birth cohort, made projections through 2030, and attributed differences in new cancer cases to demographic and epidemiologic changes. MATERIAL AND METHODS: Incidence data...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiangbo, Du, Jianqiang, Wang, Xiaoyan, Wu, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333670/
https://www.ncbi.nlm.nih.gov/pubmed/37194221
http://dx.doi.org/10.1111/aogs.14596
_version_ 1785070713832472576
author Chen, Xiangbo
Du, Jianqiang
Wang, Xiaoyan
Wu, Xiaoming
author_facet Chen, Xiangbo
Du, Jianqiang
Wang, Xiaoyan
Wu, Xiaoming
author_sort Chen, Xiangbo
collection PubMed
description INTRODUCTION: This study analyzed the incidence of ovarian cancer in Hong Kong and its association with age, calendar period and birth cohort, made projections through 2030, and attributed differences in new cancer cases to demographic and epidemiologic changes. MATERIAL AND METHODS: Incidence data for ovarian cancer were obtained from the Hong Kong Cancer Registry. We employed the age‐period‐cohort modeling approach to investigate the association between ovarian cancer incidence and age in Hong Kong women, with particular emphasis on examining the changing trends of period and cohort effects on incidence. We projected the incidence of ovarian cancer in Hong Kong between 2018 and 2030 and attributed the rise in new cancer cases to epidemiologic and demographic shifts. RESULTS: Between 1990 and 2017, a total of 11 182 women were diagnosed with ovarian cancer in Hong Kong. Crude and age‐standardized rates increased from 8.2 and 7.8 per 100 000 person‐years to 16.3 and 11.5 per 100 000 person‐years, respectively. New cases of ovarian cancer rose from 225 in 1990 to 645 in 2017. We observed an increased risk of ovarian cancer throughout the study period and in the post‐1940 birth cohort. The projected incidence rate and new cases of ovarian cancer are expected to continue growing due to demographic and epidemiologic changes such as fertility patterns and lifestyle factors, with an estimated 981 cases in 2030. CONCLUSIONS: The period risk and cohort risk of ovarian cancer among Hong Kong women is increasing. Demographic and epidemiologic changes may continue to increase ovarian cancer incidence and new cases in Hong Kong.
format Online
Article
Text
id pubmed-10333670
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103336702023-07-12 Trends and projections of ovarian cancer incidence in Hong Kong: A population‐based study Chen, Xiangbo Du, Jianqiang Wang, Xiaoyan Wu, Xiaoming Acta Obstet Gynecol Scand Oncology INTRODUCTION: This study analyzed the incidence of ovarian cancer in Hong Kong and its association with age, calendar period and birth cohort, made projections through 2030, and attributed differences in new cancer cases to demographic and epidemiologic changes. MATERIAL AND METHODS: Incidence data for ovarian cancer were obtained from the Hong Kong Cancer Registry. We employed the age‐period‐cohort modeling approach to investigate the association between ovarian cancer incidence and age in Hong Kong women, with particular emphasis on examining the changing trends of period and cohort effects on incidence. We projected the incidence of ovarian cancer in Hong Kong between 2018 and 2030 and attributed the rise in new cancer cases to epidemiologic and demographic shifts. RESULTS: Between 1990 and 2017, a total of 11 182 women were diagnosed with ovarian cancer in Hong Kong. Crude and age‐standardized rates increased from 8.2 and 7.8 per 100 000 person‐years to 16.3 and 11.5 per 100 000 person‐years, respectively. New cases of ovarian cancer rose from 225 in 1990 to 645 in 2017. We observed an increased risk of ovarian cancer throughout the study period and in the post‐1940 birth cohort. The projected incidence rate and new cases of ovarian cancer are expected to continue growing due to demographic and epidemiologic changes such as fertility patterns and lifestyle factors, with an estimated 981 cases in 2030. CONCLUSIONS: The period risk and cohort risk of ovarian cancer among Hong Kong women is increasing. Demographic and epidemiologic changes may continue to increase ovarian cancer incidence and new cases in Hong Kong. John Wiley and Sons Inc. 2023-05-16 /pmc/articles/PMC10333670/ /pubmed/37194221 http://dx.doi.org/10.1111/aogs.14596 Text en © 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Oncology
Chen, Xiangbo
Du, Jianqiang
Wang, Xiaoyan
Wu, Xiaoming
Trends and projections of ovarian cancer incidence in Hong Kong: A population‐based study
title Trends and projections of ovarian cancer incidence in Hong Kong: A population‐based study
title_full Trends and projections of ovarian cancer incidence in Hong Kong: A population‐based study
title_fullStr Trends and projections of ovarian cancer incidence in Hong Kong: A population‐based study
title_full_unstemmed Trends and projections of ovarian cancer incidence in Hong Kong: A population‐based study
title_short Trends and projections of ovarian cancer incidence in Hong Kong: A population‐based study
title_sort trends and projections of ovarian cancer incidence in hong kong: a population‐based study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333670/
https://www.ncbi.nlm.nih.gov/pubmed/37194221
http://dx.doi.org/10.1111/aogs.14596
work_keys_str_mv AT chenxiangbo trendsandprojectionsofovariancancerincidenceinhongkongapopulationbasedstudy
AT dujianqiang trendsandprojectionsofovariancancerincidenceinhongkongapopulationbasedstudy
AT wangxiaoyan trendsandprojectionsofovariancancerincidenceinhongkongapopulationbasedstudy
AT wuxiaoming trendsandprojectionsofovariancancerincidenceinhongkongapopulationbasedstudy